NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NEI E-050-2015-0-AU-04 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa AU National Stage 2016228751 Issued
NHLBI E-113-2013-0-US-03 Demodulation Of Intensity Modulation In X-ray Imaging US National Stage 15/021,675 9939392 Issued PDF
NEI E-050-2015-0-PCT-03 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa PCT PCT PCT/US2016/022072 Expired
NEI E-050-2015-0-CA-05 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa CA National Stage 2979229 Pending
NCI E-056-2011-0-SG-46 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer SG DIV 10201601913R Pending
NIAID E-064-2015-2-EP-04 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use EP National Stage 16711090.7 Issued
NIAID E-064-2015-2-FR-07 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use FR EP 16711090.7 Issued
NIAID E-064-2015-2-DE-06 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use DE EP 16711090.7 Issued
NIAID E-064-2015-2-GB-08 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use GB EP 16711090.7 Issued
NCI E-234-2010-1-AU-07 Biomarkers For Prostate Cancer And Methods For Their Detection AU DIV 2016201526 Abandoned
NIAID E-064-2015-2-PCT-01 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use PCT PCT PCT/US2016/021571 Expired
NIAID E-064-2015-2-AU-02 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use AU National Stage 2016229130 Abandoned
NIAID E-064-2015-2-CA-03 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use CA National Stage 2979038 Pending
NCI E-340-2007-0-US-12 Methods and Compositions for the Treatment of Prostate Related Disorders using miR-1 US DIV 15/062,404 Abandoned
NIDCR E-257-2012-0-US-03 Methods of Preventing the Development of Mucositis and Related Disorders US CON 15/063,256 Abandoned
NCI E-340-2007-0-US-15 Methods and Compositions for Increasing the Efficacy of Doxorubic in Treatment in the Treatment of Prostate Related Disorders using miR-106b-25 Cluster US DIV 15/062,414 Abandoned
NCI E-340-2007-0-US-14 Methods and Compositions for the Treatment of Prostate Related Disorders using miR-32 US DIV 15/062,411 Abandoned
NCI E-340-2007-0-US-13 Methods and Compositions for the Treatment of Prostate Related Disorders using miR-106b US DIV 15/062,407 Abandoned
NHGRI E-282-2012-2-US-01 Cannabinoid Receptor Mediating Compounds US CIP 15/061,829 11155521 Issued PDF
NCI E-290-2006-2-US-34 Methods of Inhibiting Tumorigenesis in Colon Adenocarcinoma and Compositions Therefor US DIV 15/057,308 Abandoned
NCI E-166-2007-0-US-07 FILIP1L Nucleic Acid Fragments US DIV 15/058,116 Abandoned
NCI E-281-2016-0-PCT-02 Quinolinones As Inhibitors Of Translation Initiation Complex PCT PCT PCT/US16/020273 Expired
NIAID E-242-2014-0-US-03 Anti-Malarial Compositions US DIV 15/056,458 1016-08-02 Issued PDF
NHLBI E-249-2006-3-US-01 Transcatheter Coronary Sinus Mitral Valve Annuloplasty Procedure and Coronary Artery and Myocardial Protection Device US CIP 15/056,599 9943409 Issued PDF
NCATS E-072-2015-0-US-15 Sensor And Device For Real Time Detection Of Metabolites In Blood US National Stage 14/915,602 Pending
NCATS E-072-2015-0-CO-09 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA CO National Stage 16051864 Pending
NCATS E-072-2015-0-KR-13 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA KR National Stage 1020167008373 Pending
NIAID E-219-2016-0-US-04 Serum Antibody Assay For Determining Protection From Malaria, And Pre-Erythrocytic Subunit Vaccines US National Stage 14/914,869 Abandoned
NIAID E-239-2014-0-PCT-02 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE PCT PCT PCT/US2016/019395 Expired
NIAID E-239-2014-0-EP-03 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE EP National Stage 16711059.2 Abandoned
NIAID E-052-2017-1-EP-01 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection EP ORD 16305211.1 Pending
NCATS E-072-2015-0-IL-11 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA IL National Stage 244274 Pending
NCI E-116-2001-0-GR-70 Formulation of Boronic Acid Compounds GR EP 16157001.5 Expired
NCI E-116-2001-0-IT-72 Formulation of Boronic Acid Compounds IT EP 16157001.5 Expired
NCI E-116-2001-0-IE-71 Formulation of Boronic Acid Compounds IE EP 16157001.5 Expired
NCI E-116-2001-0-SE-78 Formulation of Boronic Acid Compounds SE EP 16157001.5 Expired
NCI E-116-2001-0-PT-77 Formulation of Boronic Acid Compounds PT EP 16157001.5 Expired
NCI E-116-2001-0-ES-66 Formulation of Boronic Acid Compounds ES EP 16157001.5 Expired
NCI E-116-2001-0-DK-65 Formulation of Boronic Acid Compounds DK EP 16157001.5 Expired
NCI E-116-2001-0-FI-67 Formulation of Boronic Acid Compounds FI EP 16157001.5 Expired
NCI E-116-2001-0-CY-63 Formulation of Boronic Acid Compounds CY EP 16157001.5 Expired
NCI E-116-2001-0-NL-76 Formulation of Boronic Acid Compounds NL EP 16157001.5 Expired
NCI E-116-2001-0-LU-74 Formulation of Boronic Acid Compounds LU EP 16157001.5 Expired
NCI E-116-2001-0-LI-73 Formulation of Boronic Acid Compounds LI EP 16157001.5 Expired
NCI E-116-2001-0-MC-75 Formulation of Boronic Acid Compounds MC EP 16157001.5 Expired
NCI E-116-2001-0-AT-60 Formulation of Boronic Acid Compounds AT EP 16157001.5 Expired
NCI E-116-2001-0-BE-61 Formulation of Boronic Acid Compounds BE EP 16157001.5 Expired
NCI E-116-2001-0-EP-59 Formulation of Boronic Acid Compounds EP DIV 16157001.5 Expired
NCI E-116-2001-0-DE-64 Formulation of Boronic Acid Compounds DE EP 16157001.5 Expired
NCI E-116-2001-0-FR-68 Formulation of Boronic Acid Compounds FR EP 16157001.5 Expired